#778 — The Industry Wire

February 20, 2026 Brian Casey 0 min read
  1. Trump tariff fallout could affect medical industry. 
  2. White House taps NIH chief to lead beleaguered CDC. 
  3. Grail’s cancer blood test falls short in massive U.K. study. 
  4. When is it unethical to not use AI?
  5. RCM firms see payor rule changes as biggest threat.
  6. Federal subsidies extend far beyond ACA policies.
  7. United Healthcare raises bar for MA specialist referral.
  8. Hims & Hers to acquire digital health firm Eucalyptus.
  9. Hospital firm CHS makes progress paying down debt.
  10. NYC nurse’s strike close to resolution. 
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like

Artificial Intelligence March 12, 2026

FDA Updates AI List with New Clearances March 12, 2026

The FDA last week updated its list of cleared AI-enabled medical devices, with the new list showing AI marketing authorizations through the end of 2025. The updated list reveals that radiology is maintaining its lead as the medical specialty with the most clearances. The FDA’s previous update featured data through the end of September 2025, […]

Radiology March 10, 2026

ECR 2026 Video Highlights March 10, 2026

The 2026 edition of the European Congress of Radiology wrapped up last weekend, and the conference was full of breaking business and clinical news. Artificial intelligence dominated the proceedings in Vienna, with researchers presenting the latest work in applying AI to breast and lung screening, neuroradiology, fracture detection, and other clinical use cases. AI was […]

Radiology March 9, 2026

Top Trends from ECR 2026 March 9, 2026

The 2026 edition of the European Congress of Radiology wrapped up last week, and both clinical and business news dominated the discussion in Vienna.  Below are the top trends from ECR 2026… The Takeaway Last week’s ECR 2026 cemented the meeting’s reputation as a European counterpoint to radiology’s other major conference, RSNA. In some areas […]